An enhancer-AAV approach selectively targeting dentate granule cells of the mouse hippocampus.

AAV CA3 CP: Neuroscience dentate gyrus enhancer gene therapies granule cells hippocampus perforant path viral targeting

Journal

Cell reports methods
ISSN: 2667-2375
Titre abrégé: Cell Rep Methods
Pays: United States
ID NLM: 9918227360606676

Informations de publication

Date de publication:
01 Jan 2024
Historique:
received: 18 05 2023
revised: 29 09 2023
accepted: 13 12 2023
medline: 12 1 2024
pubmed: 12 1 2024
entrez: 11 1 2024
Statut: aheadofprint

Résumé

The mammalian brain contains a diverse array of cell types, including dozens of neuronal subtypes with distinct anatomical and functional characteristics. The brain leverages these neuron-type specializations to perform diverse circuit operations and thus execute different behaviors properly. Through the use of Cre lines, access to specific neuron types has improved over past decades. Despite their extraordinary utility, development and cross-breeding of Cre lines is time consuming and expensive, presenting a significant barrier to entry for investigators. Furthermore, cell-based therapeutics developed in Cre mice are not clinically translatable. Recently, several adeno-associated virus (AAV) vectors utilizing neuron-type-specific regulatory transcriptional sequences (enhancer-AAVs) were developed that overcome these limitations. Using a publicly available RNA sequencing (RNA-seq) dataset, we evaluated the potential of several candidate enhancers for neuron-type-specific targeting in the hippocampus. Here, we demonstrate that a previously identified enhancer-AAV selectively targets dentate granule cells over other excitatory neuron types in the hippocampus of wild-type adult mice.

Identifiants

pubmed: 38211592
pii: S2667-2375(23)00370-3
doi: 10.1016/j.crmeth.2023.100684
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100684

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Emmie Banks (E)

Department of Cell Biology, Emory University School of Medicine, Atlanta, GA 30322, USA; GDBBS Graduate Program, Laney Graduate School, Emory University, Atlanta, GA 30322, USA.

Claire-Anne Gutekunst (CA)

Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA 30322, USA.

Geoffrey A Vargish (GA)

Section on Cellular and Synaptic Physiology, NICHD - Eunice Kennedy Shriver National Institute of Child Health, Bethesda, MD, USA.

Anna Eaton (A)

Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA 30322, USA; Human Development, National Institutes of Health (NIH), Bethesda, MD, USA.

Kenneth A Pelkey (KA)

Section on Cellular and Synaptic Physiology, NICHD - Eunice Kennedy Shriver National Institute of Child Health, Bethesda, MD, USA.

Chris J McBain (CJ)

Section on Cellular and Synaptic Physiology, NICHD - Eunice Kennedy Shriver National Institute of Child Health, Bethesda, MD, USA.

James Q Zheng (JQ)

Department of Cell Biology, Emory University School of Medicine, Atlanta, GA 30322, USA.

Viktor Janos Oláh (VJ)

Department of Cell Biology, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address: viktor.janos.olah@emory.edu.

Matthew J M Rowan (MJM)

Department of Cell Biology, Emory University School of Medicine, Atlanta, GA 30322, USA; Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address: mjrowan@emory.edu.

Classifications MeSH